B

BlinkLab Ltd
ASX:BB1

Watchlist Manager
BlinkLab Ltd
ASX:BB1
Watchlist
Price: 0.92 AUD -1.6% Market Closed
Market Cap: AU$81m

BlinkLab Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BlinkLab Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
B
BlinkLab Ltd
ASX:BB1
Research & Development
-AU$2.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Research & Development
-AU$852.4k
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Artrya Ltd
ASX:AYA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BlinkLab Ltd
Glance View

Market Cap
81m AUD
Industry
Health Care

An app that turns an ordinary mobile phone into a device for conducting objective neurobehavioral tests could make it easier and more cost-effective to diagnose neurological disorders. The company is headquartered in Sydney, New South Wales. The company went IPO on 2024-04-04. The Company’s tests include eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response, which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests). The BlinkLab Device (BlinkLab Dx) consists of BlinkLab App, a mobile application for patients, caregivers and/or parents, effectively a front-end tool that helps collect test subjects’ information and responses to the BlinkLab Tests in real time (BlinkLab App), and BlinkLab Portal, which includes a fully built secure database and content management system (CMS) as well as experimenter’s portal that allows for full customization of the neurometric tests as well as data analysis, annotation and visualization tools (the BlinkLab Portal).

BB1 Intrinsic Value
4.07 AUD
Undervaluation 77%
Intrinsic Value
Price
B

See Also

What is BlinkLab Ltd's Research & Development?
Research & Development
-2.6m AUD

Based on the financial report for Jun 30, 2025, BlinkLab Ltd's Research & Development amounts to -2.6m AUD.

What is BlinkLab Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-1 344%

Over the last year, the Research & Development growth was -1 344%.

Back to Top